Cervical Neoplasia Incidence After HPV Vaccination
Decreases in cervical intraepithelial neoplasia (CIN) on the population level among patients vaccinated for the human papillomavirus (HPV) should be considered.
Decreases in cervical intraepithelial neoplasia (CIN) on the population level among patients vaccinated for the human papillomavirus (HPV) should be considered.
Only 1 in 5 parents support laws requiring human papillomavirus (HPV) vaccination for school attendance.
Researchers found that vaccination for HPV should be given in 2 doses, at least 6 months apart for routine vaccinations of young girls.
The human papillomavirus (HPV)-16/18 vaccine appears to protect against the viral strain even after one or two doses.
Many American college students don’t fully understand the threat posed by the human papillomavirus (HPV) or their risk for infection.
Males benefit indirectly when girls are immunized against human papillomavirus (HPV).
The quadrivalent human papillomavirus (HPV4) vaccine appears to be cost-effective for the prevention of oropharyngeal cancer (OPC).
Mixed views in relation to explaining causal role of human papillomavirus (HPV) in oropharyngeal cancer.
The National Cancer Institute (NCI) has funded $3.5 million for the development of a new human papillomavirus (HPV) vaccine.
Results of ADXS-HPV with standard chemo and radiotherapy for HPV-associated anal cancer who have a high risk of recurrence.